Short description
Theravasc is a biotechnology company developing repurposed drugs for vascular disease markets.
Description
TheraVasc, Inc., a biotechnology company, develops repurposed drugs for vascular disease markets. It offers TV1001, an oral formulation of sodium nitrite that targets patient populations with poor blood flow to the extremities, such as those with diabetic leg and foot problems, and peripheral artery disease. The company was incorporated in 2009 and is based in Cleveland, Ohio.
Total funding
$$2020202
Sign in for full access
Location
Cleveland, Ohio, United States, North America
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, No Way, Nopepepe, Noaccessforu, Noaccess
Sign in for full access
Founders
Chris Kevil, Tony Giordano